Navigation Links
New Research from Best Practices, LLC Helps Medical Device Companies Earn the Highest Profit Possible During Their Product's Patent Lifecycle

CHAPEL HILL, N.C., March 2 /PRNewswire/ -- The medical device industry, which comprises nearly $300 billion in annual revenue, has taken considerable heat in the recent healthcare reform debates.  Though medical device companies historically have been able to realize returns on investment far more quickly than traditional pharmaceutical companies due to a more simplified FDA approval process for new medical equipment and technologies, device companies must also contend with shorter patent protections and lower growth rates than branded pharmaceuticals.

Now, with a Congressional plan proposing a $40 billion tax on the medical device industry over the next 10 years to help pay for healthcare reform, these firms face mounting internal and external pressure to keep their pricing structure as low as possible.  To make matters worse, a similar plan requiring hospitals to endure a $155 billion diminution in Medicare payments over the same 10-year window would also work to erode the wherewithal of one of the medical device industry's largest customer bases.

In sum, for medical device executives facing this economic and political maelstrom which could drastically undermine the profitability of the device industry, there has never been a more critical time to evaluate and bolster the organizational levers that drive innovation, efficiency, and real revenue growth.

To this backdrop, Best Practices, LLC has released a timely benchmarking study to enable medical device leaders to set new strategies and tactics and streamline their activities and staffing to maximize profitability.  This study, Performance Benchmark: Optimizing Staff Levels to Drive Growth in Medical Devices, benchmarks industry leaders like Abbott Labs, Becton Dickinson, Hospira, LifeScan, Medtronic, Stryker to reveal how elite medical device companies can succeed in this challenging environment and marketplace.  Topics highlighted in this research include staffing and productivity levels based on revenue, industry growth and profit margins based on investment, and strategic marketing activities that provide the greatest return for company resources.

To download a complimentary sample of this study, please click:

To learn more about Best Practices' other timely research visit: or contact Benjamin Gregory at 919-767-9160 or


Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC

Back to top



SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
(Date:11/25/2015)... -- The American Academy of Pediatrics (AAP), American Congress ... of Dimes cheered today,s signature into law of ... 2015 (S.799), which takes much-needed strides to ... drugs, such as opioids, and to improve their ... have worked together leading advocacy efforts for its ...
(Date:11/25/2015)... Nov. 25, 2015  Henry Schein, Inc., the world,s ... office-based dental, medical and animal health practitioners, will unveil ... Henry Schein ConnectDental® Pavilion , which brings together ... open solutions designed to help any practice or laboratory ... for a schedule of experts appearing at the ...
(Date:11/25/2015)... 25, 2015 Allergan plc (NYSE: ... Rugen Therapeutics, a start-up  biotechnology company focused on ... disorders and funded by the F-Prime Biomedical Research ... into an exclusive collaboration to support the discovery ... Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology:
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., ... the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by ... through Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention ...
(Date:11/25/2015)... ... 25, 2015 , ... As part of a global movement ... volunteers together who want to combine talents and resources to help create sustainable ... process. The non-profit launched its first major fundraiser on November 6, 2015 at ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical ... more about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared ... thicker and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
Breaking Medicine News(10 mins):